<DOC>
	<DOCNO>NCT01277783</DOCNO>
	<brief_summary>The ALternate site cardiac reSYNChronization ( ALSYNC ) study , non-comparative , prospective , non-randomized , multi-national clinical investigation . The purpose clinical investigation evaluate safety performance investigational atrial transseptal endocardial LV lead delivery system implant procedure deliver SelectSecure® Model 3830 lead Left Ventricle via superior approach , evaluate performance SelectSecure® Model 3830 lead Left Ventricle .</brief_summary>
	<brief_title>ALternate Site Cardiac ReSYNChronization ( ALSYNC ) Study</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Cardiac Resynchronization Therapy candidate/recipient : Failed Cardiac Resynchronization Therapy implant require CRT replacement without viable access Coronary sinus , Suboptimal Coronary sinus anatomy per investigator discretion , Worsened unchanged clinical status Cardiac Resynchronization Therapy implant Patients able willing take optimal Vitamin K antagonist therapy ( INR 24 ) Patients willing sign date Patient Informed Consent form Patients 18 year age old Patients able willing comply protocol , expect remain available followup visit Patients contraindication Vitamin K antagonist therapy Patients contraindicate &lt; 100 microgram beclomethasone dipropionate Patients unable tolerate urgent thoracotomy Documented ( previous ) ischemic hemorrhagic stroke Patients know previous atrial septal defect closure , history mural thrombus resolve Patients document atrial fibrillation AND increase stroke risk determine Congestive Heart Failure , Hypertension , Age ( 2 ) , Diabetes , Stroke ( 2 ) , Vascular disease , Age , Sex Category ( CHA2DS2VASc ) Score equal great 5 Patients unstable angina pectoris acute myocardial infarct within past 30 day Patients known ASD and/or leave superior vena cava Patient know internal carotid artery stenosis great 50 % Patients diagnosed peripheral artery disease expect undergo stenting within next three month Patients Coronary artery bypass graft stent within past three month Patients history mitral aortic valve repair replacement Post heart transplant patient ( patient wait heart transplant allow study ) Patients currently undergoing dialysis treatment Patients ongoing chemotherapy radiation therapy may effect cardiac function Patients ongoing Adverse Events previous Left Ventricle lead implant attempt Patients enrol concurrent drug and/or device study may confound result study Patients expect survive twelve month Patients exclusion criterion require local law</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>